OMRF and Stanford have received a four-year grant to use zebrafish to study how small genetic variations can lead to several human diseases.
The grants will support more than 50 research and clinical projects, purchase scientific equipment and fund recruitment.
New findings could help scientists develop treatments for the condition known as ITP.
This collaboration is part of GSK’s “Discovery Partnerships with Academia” (DPAc) efforts.
Visiting attendees represented some of the top names in in the industry.
OMRF and three other institutions are jointly studying age-related muscle loss.